Role of tumor-associated immune cells in prostate cancer: angel or devil? / 亚洲男科学杂志(英文版)
Asian Journal of Andrology
;
(6): 433-437, 2019.
Artigo
em Inglês
| WPRIM
| ID: wpr-1009744
ABSTRACT
Prostate cancer is the most common malignancy in the reproductive system of older males. Androgen deprivation therapy (ADT) is an important treatment for prostate cancer patients. However, almost all prostate cancer patients unavoidably progress to the castration-resistant stage after ADT treatment. Recent studies have shown that tumor-associated immune cells play major roles in the initiation, progression, and metastasis of prostate cancer. Various phenotypes of tumor-associated immune cells have tumor-promoting or antitumor functions mediated by interacting with tumor cells. Here, we review the current knowledge of tumor-associated immune cells in prostate cancer.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Neoplasias da Próstata
/
Linfócitos do Interstício Tumoral
/
Progressão da Doença
/
Neoplasias de Próstata Resistentes à Castração
/
Macrófagos
/
Neutrófilos
Limite:
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Asian Journal of Andrology
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS